Penn Capital Management Company, LLC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 65 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Penn Capital Management Company, LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$6,470,000
-13.4%
2,675,000
-29.7%
0.27%
-6.9%
Q2 2014$7,470,0003,805,0000.29%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
GRACE BROTHERS MANAGEMENT LLC 2,800,000$6,773,0006.36%
SILVERBACK ASSET MANAGEMENT LLC 19,709,000$47,671,0005.58%
Sage Capital Management, LLC 1,660,000$4,009,0003.83%
SYMPHONY ASSET MANAGEMENT LLC 15,190,000$36,741,0003.79%
BASSO CAPITAL MANAGEMENT, L.P. 8,187,000$19,782,0003.03%
CAMDEN ASSET MANAGEMENT L P /CA 29,798,000$72,074,0003.00%
Wellesley Asset Management 15,250$36,969,0002.29%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,600,000$20,801,0002.12%
BNP PARIBAS FINANCIAL MARKETS 7,500,000$1,814,100,096,0001.58%
WOLVERINE ASSET MANAGEMENT LLC 31,156,000$75,372,0001.57%
View complete list of SALIX PHARMACEUTICALS INC shareholders